Jane Street’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Jane Street’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-51,100	Closed	-$175K	–	11032
2021 Q3	$175K	Buy	+51,100	New	+$158K	﹤0.01%	8951

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's INFI Position: Q1 2023 in Review

Jane Street sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 147,550 shares — an estimated $81.9K sold.

Jane Street first reported a position in INFI in Q1 2014 and held it in 9 quarters. The position peaked at $857K in Q3 2021. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.

Jane Street reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Jane Street sold 147,550 Infinity Pharmaceuticals, Inc. shares in Q1 2023, an estimated $81.9K.
Jane Street first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 9 quarters.
Jane Street's Infinity Pharmaceuticals, Inc. position peaked at $857K in Q3 2021.
53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.